nForm Blog
Category: 3D Biology™ Technology
3D Biology™ Technology Q&A
Q&A with Dr. Sergio Rutella: Multi-analyte studies in acute myeloid leukemia
Sergio Rutella, M.D., Ph.D. FRCPath is a Professor of Cancer Immunotherapy at the John van Geest Cancer Research Centre at Nottingham Trent University. His research focuses on acute myeloid leukemia…
3D Biology™ Technology Q&A
Q&A with Dr. David Coffey, FHCRC: Multi-analyte studies in multiple myeloma and lymphoma
David Coffey, MD, is a physician scientist with the Fred Hutchinson Cancer Research Center in Seattle, Washington. When he’s not treating patients, he’s in the lab researching blood cancers such…
3D Biology™ Technology
Moving Toward the Clinic- Leveraging Xenograft Models for Preclinical Anti-Cancer Studies
The use of cancer cell lines for in vitro studies of anti-cancer agents remains a primary component of preclinical drug development. These studies, however, struggle with significant pitfalls given the…
3D Biology™ Technology
Taking off the Blinders- The Acceleration of Integrated Multi-omic Analysis
Typically our fields require us to specialize; geneticists profile DNA and RNA, flow cytometrists look at extracellular protein markers, and system biologists look at complex data from six different instruments. We often…
3D Biology™ Technology
Getting More from Flow Cytometry
Immunology studies rely on identifying unique cell populations, such as T cells and B cells, and then analyzing these cells to understand the biology of these cells. Studying different types…
3D Biology™ Technology Q&A
Multi-Analyte Analysis of Lung Cancer FFPE Samples with 3D Biology™ Technology
NanoString sat down with McGarry Houghton, M.D., Associate Member of the Clinical Research and Human Biology Divisions at Fred Hutch Cancer Research Center, to discuss how his lab is using…
3D Biology™ Technology
Researcher Profiles: How NanoString® Grant Program Winners are Utilizing 3D Biology™ Technology
This past February, four grant program applicants were awarded nCounter Vantage 3D™ Assays of their choice to profile 36 samples. NanoString followed up with each of the winners to explore…
3D Biology™ Technology Q&A
Monitoring Clinically Actionable Proteins- A Q&A with Gordon Mills, MD Anderson Cancer Center
NanoString sat down with Gordon Mills, M.D., Ph.D., Chair of Systems Biology Department at MD Anderson Cancer Center in Houston and lead developer of The Cancer Proteome Atlas (TCPA), to…
3D Biology™ Technology
3D Biology™ Technology Measures DNA, RNA, and Protein Simultaneously
3D Biology™ Technology* Measures DNA, RNA, and Protein Simultaneously, Preserving Samples By Joe Beechem, Senior Vice President of Research and Development *For Research Use Only. Not for use in Diagnostic…